NCT00318370 2015-09-09Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based ChemotherapyMorphotekPhase 2 Completed58 enrolled 12 charts
NCT01004380 2014-07-17Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian CancerMorphotekPhase 1 Completed15 enrolled